Tumor-suppressor activity of RRIG1 in breast cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Zhang, Guihong ^a,b   Brewster, Abenaa ^a   Guan, Baoxiang ^a   Fan, Zhen ^a   Brown, Powel H ^a   Xu, Xiao Chun ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; PROTEIN C JUN; PROTEIN KINASE B; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; COMPLEMENTARY DNA; MEMBRANE PROTEIN; RRIG1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; RETINOID RECEPTOR INDUCED GENE 1; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA, ANTISENSE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 78951479268     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-32     Document Type: Article

References (31)

1. Wu K, Zhang Y, Xu XC, Hill J, Celestino J, Kim HT, Mohsin SK, Hilsenbeck SG, Lamph WW, Bissonette R, Brown PH. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Cancer Res 2002, 62:6376-6380.
2. DeVita VT, Hellman S, Rosenberg SA, . (eds) Cancer: Principles and Practice of Oncology. 1997, 1541-1616. Philadelphia and New York: Lippincott-Raven Publishers, (eds).
3. Fidler I, Nicholson G. Concepts and mechanisms of breast cancer metastasis. The Breast 1991, 395-408. Philadelphia: WB Saunders, Bland K, Copeland E.
4. Fidler IJ. Molecular biology of cancer: invasion and metastasis. Cancer: Principles and Practice of Oncology 1997, 135-152. Philadelphia and New York: Lippincott-Raven Publishers, DeVita VT Jr, Hellman S, Rosenberg SA.
5. Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC. RRIG1 mediates effects of retinoic acid receptor-β2 on tumor cell growth and gene expression through binding to and inhibiting RhoA. Cancer Res 2006, 66:7111-7118. 10.1158/0008-5472.CAN-06-0812, 16849557.
6. Huang J, Liang ZD, Wu TT, Hoque A, Chen H, Jiang Y, Zhang H, Xu XC. Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer. Cancer Res 2007, 67:1589-1593. 10.1158/0008-5472.CAN-06-2472, 17308098.
7. Guan B, Li H, Chen Y, Hoque A, Xu X-C. Characterization of retinoid receptor-induced gene-1 gene and its relationship to SH3 domain GRB2-like endophilin B2 gene. J Cancer Mol 2009, 5:15-19.
8. Hoque A, Chen H, Guan B, Xu X-C. Tumor-suppressive effect of RRIG1 in prostate cancer. Proc Amer Assoc Cancer Res 2009, 50:5334.
9. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999, 59:2477-2483.
10. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235. 10.1038/73432, 10700174.
11. Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002, 55:294-299. 10.1136/mp.55.5.294, 1187258, 12354931.
12. Song S, Xu X-C. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 2001, 281:872-877. 10.1006/bbrc.2001.4433, 11237740.
13. Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu X-C. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-b2 expression. Oncogene 2005, 24:8268-8276. 10.1038/sj.onc.1208992, 16170369.
14. Xu X-C. Risk factors and gene expression in esophageal cancer. Cancer Epidemiology, Vol. I, Host Susceptibility Factors 2009, 335-360. Humana Press, Verma M.
15. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 1997, 57:4992-4996.
16. Widschwendter MJ, Berger G, Daxenbichler E, Muller-Holzner A, Widschwendter A, Mayr A, Marth C, Zeimet AG. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997, 57:4158-4161.
17. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995, 6:1077-1088.
18. Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, Xu X-C. Prognostic significance of MMP-9 and TIMP-1 expression in breast cancer. Int J Cancer 2008, 122:2050-2056. 10.1002/ijc.23337, 18172859.
19. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999, 96:2110-2115. 10.1073/pnas.96.5.2110, 26745, 10051603.
20. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005, 9:59-71. 10.1111/j.1582-4934.2005.tb00337.x, 15784165.
21. Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, Shimada Y, Ari-i S, Wada H, Fujimoto J, Kohno M. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999, 18:813-822. 10.1038/sj.onc.1202367, 9989833.
22. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. BBA-Mol Cancer Res 2007, 1773:1263-1284.
23. Syed Z, Cheepala SB, Gill JN, Stein J, Nathan CA, Digiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prev Res 2009, 2:903-911.
24. Yuan ZL, Guan YJ, Wang L, Wei W, Kane AB, Chin YE. Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol 2004, 24:9390-9400. 10.1128/MCB.24.21.9390-9400.2004, 522220, 15485908.
25. Silva CM. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 2004, 23:8017-8023. 10.1038/sj.onc.1208159, 15489919.
26. Alexandropoulos K, Cheng G, Baltimore D. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci USA 1995, 92:3110-3114. 10.1073/pnas.92.8.3110, 42114, 7536925.
27. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002, 2:133-142. 10.1038/nrc725, 12635176.
28. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79. 10.1016/S1535-6108(03)00162-4, 12892714.
29. Gomez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC. Rho GTPase expression in tumorigenesis: evidence for a significant link. Bioessays 2005, 27:602-613. 10.1002/bies.20238, 15892119.
30. Sahai E, Marshall CJ. Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signaling and extracellular proteolysis. Nat Cell Biol 2003, 5:711-719. 10.1038/ncb1019, 12844144.
31. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999, 59:2004-2010.